Reddit Posts
ARKK's Misfits - A Bet on the Comeback Kings:
CRSPR, Intellia, Beam, Pacific Biosciences, Illumnia, Editas, Invitae... Will any of these companies be huge in the future?
🚀 $37k YOLO DD on Nutella (NTLA) - The Sweetest Play in the Market 🚀
$CRSP CRISPR Therapeutics pending EMA and FDA Aprovel
Hot Stocks: OKTA, KR rise on earnings news; PLUG drops; NTLA climbs as FDA clears trial
Bought NTLA options with 0 volume only one who has shares at strike price 40
What are your thoughts on ARKG ETF now as a long-term play?
What are the worst / most overvalued stocks on the market?
Searing Criticism on ARK's Genomic Bets in FT. What do you think?
CRISPR DD that's not only lazy, but also manages to stack a few levels of uncertainly, meaning only a fool would give this any credence...
Big Pharma destroying small cap Biotech SGMO
Where’s the volume for gene editing stocks (CRSP, EDIT, NTLA, BEAM, etc.)?
DD on DTIL (gene editing company) I am hoping people can critique
Analysis: Stock Trading by U.S. Senators and Representatives
Analysis: Stock Trading by U.S. Senators and Representatives
$BLUE is going to make me green
CRISPR Short Squeeze Coming in Sep
I built a program that tracks mentions and sentiment of stocks across Reddit and Twitter! This week's most discussed and top growing stocks!
$EDIT - up 25% today since my last post yesterday, still a lot of room to run
Listen up degens, EDIT isn't just a soaring stock - it will help humanity
$DTIL fraction of $NTLA and $VERV but same capabilities
Listen up degens, EDIT isn't just a soaring stock - it will help humanity
$ORTX - Massively undervalued GENE therapy co.
$ORTX - Massively undervalued GENE therapy co.
Looking for advice on understanding exit strategies in regards to biotech companies
Intellia Therapeutics to the moon 🌙. $NTLA
Intellia Therapeutics, Inc. (NASDAQ:NTLA), has commenced an underwritten public offering of $400 million of shares of its common
First in-vivo gene editing therapy announces positive results
have you guys heard of intellia therapeutics? (NTLA) gene editing
$NTLA Intellia Therapeutics (CRISPR technology). Might close out or roll the short position. Let's see if it pops Monday. Advice?
$NTLA and $REGN announce that they have successfully corrected a hereditary disease with an infusion of CRISPR
$NTLA and $REGN announce that they have successfully corrected a hereditary disease with an infusion of CRISPR
NTLA, CRSP, EDIT, BEAM, VERV, ARKG likely to fly on Monday
NTLA, BEAM, CRSP, VERV, EDIT, and ARKG likely to fly on Monday
Let’s get a round of applause for all the people who DON’T buy!
Twist Bioscience (TWST) - great biotech play and also working with Microsoft on the future of data storage. Let me know what you think!
$EDIT - your chance to get the breading on your tendies a bit crispr.
$NTLA - poised for growth at a CRISP pace
Mentions
I thought NTLA was short for nutella and now I’m broke
Yeah that was a great lesson for me. I bought at $1.12, and saw that 7x and thought it would keep going. Then I held when it dipped, and went back to $4. And I should have sold then, but thought it would go up so I waited. Then I saw $3.50 and thought I’d wait for it to go back to $4. Then it went to 2.90 and I thought I’d wait until it went to $3. And then I finally sold at $2.76. Still made a couple grand, but not what I could have! First time trading, this taught me a lot 😆. Taking emotion and hope out and approaching things moving forward with more calculation and having firm entry and exit positions. Bought ASST this morning at $1.47 and when it stayed at $1.50 for a couple hours I just sold and looked at NTLA’s dip and bought in there at $13.70. That’s back up to $14.70, I’m going to get out of there soon too.
Y'all having a great day while I sit on NTLA.
I'm looking at $NTLA as well. One thing I don't like is that stock recovery isn't 100% post-event. I might trade sideways for a bit before moving back up. Examples below didn't really recover and still well below pre-event. Some concerns chatGPT shared with me: Here are a few recent situations that closely map to the scenario you’re dealing with (lead asset, trial pause, safety event) — with how they played out. • Rocket Pharmaceuticals (RCKT) – gene therapy for Danon disease A patient in their Phase 2 pivotal trial (RP-A501) died following a capillary-leak syndrome and acute systemic infection. → The trial was voluntarily paused and the FDA placed a hold. → Stock plunged \~60% intraday. → Later resumed with lower dose; stock recovered \~20% but stayed below prior levels. Takeaway: Safety event ⇒ big drop; resumption ⇒ partial rebound. • Sarepta Therapeutics (SRPT) – gene therapy for Duchenne muscular dystrophy (DMD) Two patient deaths from acute liver failure triggered a pause in shipments and trials. → Stock dropped >40% on the news. Takeaway: Even approved products face serious valuation risk after safety events. • Novavax (NVAX) – vaccine candidate trial hold A motor-neuropathy case in a Phase 2 trial led to an FDA clinical hold. → Stock dropped \~19%. Takeaway: Safety issue in even lower-risk areas causes sharp market reactions. • Intellia Therapeutics (NTLA) One patient developed Grade 4 liver enzyme elevation → company paused dosing in Phase 3 MAGNITUDE trial of nex-z. → Shares fell \~45% pre-market. Important nuance: single patient (\~450+ dosed), appears reversible but still triggered protocol pause. Watch: causality, regulator feedback, protocol changes, resumption timeline.
Ouch NTLA baggies made today
How is NTLA not at $5 right now? Expected value is 0. Another Cathie masterclass.
Wow NTLA down almost 50% did they find something bad in the Nutella or something
Maybe don't panic sell NTLA. I saw another post where the OP says there are health concerns in their trials, but it only happened to one very old dude who is doing fine now. If that is true, this sounds like market overreaction and it will go back up. I don't know if it is, I'm at work and I can't do my own research, but it does sound like it. If that is actually an overreaction, selling now is unwise. It's important to note that I have no skin in the game, so it's easy for me to say what I am saying. I wish I could actually research this, as, if the previous post is accurate, this seems like a good chance to get some quick returns from the overreaction.
Holding CODX, and riding the recovery wave of NTLA (not a penny stock) for some quick gains.
I did a little of the BYND, lost like a grand, finally came to terms with being a huge dumbass and accepted it. this morning NTLA crashed and I lost like 1500 in gains from that. its joever.
Yeah, it went down because of NTLA
A couple of NTLA trials were paused due to liver damage in a patient. I guess the immediate reaction is that this is a potential risk for any crispr trials. Personally, I've loaded up on a few discount crispr stocks in the last 30 mins as I think it's an overreaction. This stuff happens all the time in clinical trials and patient safety is first priority. This was one of 450 patients enrolled in the trial
Why has NTLA trading been halted? It’s only up 2.54%
NTLA, up 208% in last 6 months, and big catalysts coming EOY, and in the next 2 years.
Anyone else here dumb enough to buy NTLA
I've kept an eye on the sector over the years, mostly just because I think it's interesting. Honestly, a lot of the specifics around the science go right over my head. For that reason, I've always found TWST interesting, but not convinced by their financials to touch them. Covid caused some weird valuation swings for the sector, so I don't put much thought into that and try to just focus on what each company is doing now. I've only got a few shares in CRSP (I'm definitely not into investing a large percentage of my portfolio in risky biotechs). I like that they keep enough cash on hand to not need to take desperate funding deals. I also like that they're one of the few with an approved treatment (CASGEVY). They've at least shown that they can bring these treatments to market. I also like NTLA, but it's been a little while since I've really looked at them.
My techmemes like NTLA and AMPX are getting shit on hard today
Move the fuck on and live your life. Focus in living. Focus on the strategy that is working for you and stick with it. If your strategy works, keep doing it. And for the love of God, just get outside and do something so you don't obsess over it all day. Past fomo experiences of mine, for the record: Sold MU a long time ago, after a 40% gain Sold AMD forever ago, 40% gain. A couple times over. Knew about Intel. Missed it Knew about NVDA. Sat on it. Knew about Tesla, sold after a 50% gain. That was in 2016 or 2017. Knew about Amazon when it's PE was 1000. Didn't touch it. Knew about NTLA also, that one has been on a tear. Right now I'm letting OKLO and PLTR just run and get me profits. In another 3 or 6 months I'll sell off the original amount I invested, but I'll keep holding those and let them run. Also I'm going to keep buying VTI. Every day VTI.
Hoping for another NTLA jump
I see how the OP changed the original post in favor of NTLA after I posted this comment 6 months ago. I am long on NTLA
They are likely waiting to release data from more recent studies that should be positive, verify the safety and science, and move the stock price higher. At that point, we should get an announcement that they will be issuing more stock or issuing convertible bonds, or possibly be acquired. A $90 share price gives NTLA a 10B market cap - completely reasonable for the science and technology. Considering there is still 30% short interest in the stock, any good news from the clinical trials could see massive short covering and an opportunity to sell stock at a higher price.
Crispr-cas9 is the hot thing in biotech right now. It’s used for gene editing and in the future gene editing will be able to solve basically any disease ever. CRBU is co-founded by the woman who co-invented the tech and also co-founded NTLA. She is working with CRBU to develope a crispr hybrid RNA-DNA (chRDNA). This chRDNA will make the existing crispr tech work better be more accurate and have less unintended gene edits which have unintended consequences. ChRDNA will make crispr safer and more effective, it is also a platform that can be patented and then CRBU can license it to all the other biotech crispr companies and make billions. Trial data for their two proof of concept therapies CB-010 and CB-011 will be released by end of year. Stock has moved from 0.66 to 2.60 in anticipation but mcap is still around 300m which means this has upside potential to easily 10-20x if the results are good. I’m betting on the competence of Jennifer Dounda who invented crispr, won a Nobel prize, and cofounded NTLA. Bad results kills the thesis but she has proven to be a good bet and the upside far outward the downside here.
Bought some NTLA this morning, already up 5%. Totally fake ass day.
NTLA chart is looking nice honestly
NTLA, BLNE, DFDV before it split. I had it at like 16. It got somewhere above 100. It split, bought more at 34, it got close to 100 again if I remember right before it declined to where it is now. Would have been pretty set if I held it
“what’s the next biotech to triple like NTLA” maybe the other company founded by the NTLA founder? CRBU leaps cause crispr is the future
I saw the ticker NTLA and thought Nutella had its own stock. Maybe I am retarded
I did. 2 stocks. NTLA, and another one i can't remember. Both tanked like a mofo. These guys are regards for a reason.
NTLA. That ticker is for Nutella correct?
Man I'm so glad I bought CRSP, EDIT, and NTLA a few months ago. CRSP +61.9% EDIT +47.2% NTLA +117.4%
NTLA now up 29% on no news
NTLA launching to outer space
Large insider buys on CRSP and NTLA, upcoming conferences, and expectations of big news
I'm in the same positions. UNH/LULU/NVO and PYPL. My other large position in NTLA since gene-editing is going to blow up in 2026.
Are there any news on NTLA?
Ahem, CRSP, JD, NTLA, and SKYT. To Valhalla.
The fact that no one is talking about NTLA is insane
Gene Editing to the Moon CRSP NTLA BEAM
Finally vindicated with NTLA, but now comes the hard part... when to sell?!?!
I like NTLA as both a short and long term play. Excited about their HAE results in January.
Hope Cathy DCAed her NTLA bet.
Yes, in hindsight, I should've sold shares at 200 and bought them back on the way down, dollar cost ave my way back to the number I previously held while enjoying the tremendous profits. NTLA's chart at the moment resembles a previous stock I held (RYTM), where, after the share price precipitously declined for \~19 months to about $3.50 on funding and data release concerns for its drugs (similar to the narrative on NTLA). Once the narrative shifted and the sell-side must've begun to pitch the stock to customers again, it first legged up to the $20s, stayed there for a bit, had a brief drawdown, but hasn't looked back since hitting $105 the other day. I sense something similar with NTLA. What has kept you in the stock, and why do you believe in the science?
You seem to have similar views I have! I have held shares through the $200 boom and have not sell even one. NTLA’s approach is something I believe in profoundly and something I want to see through :)
If you are interested on what I believe is the next big thing short term, look for NTLA and their in vivo crispr ;) my portfolio is currently 60% NTLA shares and leaps.
I've owned Intellia \~7k shares since 2016. I am having an internal debate on the rise in the stock's price. I believe in the stock (and science) long-term, and I have thought of selling shares at a loss to purchase LEAPs so that I can free up some capital in my portfolio. However, the current administration seems less friendly to CRISPR-based science, and I would fear that the LEAPs I purchase could be severely hit should the administration act irrationally toward it in 2026. LEAPs are also relatively expensive as IV has skyrocketed over the last two weeks. My hope has always been that NTLA would be taken over by Regeneron for 10B market cap or \~$90 per share.
NVDA is a long term hold, NTLA is more of a ''target sell'' swing trade ; pharmaceutical are really hard to hold long term, always kind of a rollercoaster ride with a lot of prayers !
Anyone else seeing gene-edit/biotech today? : O CRSP and NTLA are going bonkers on heavy volumes
Someone DD NTLA
I’ve had this on a watchlist for 4 months. No news and 3x volume today… Unless someone has the scoop, I’m wondering if it’s being pulled up by the PFE jet stream. a lot of bio tech and healthcare seemed to move over the last 48 hours on the Pfizer news. $NTLA, $ABCL, $NUVB (yesterday), $MRNA, $NVAX, $MERCK… all up.
good or bad sign my calls on two stocks keep going to .01 bc no market interest? i must be right.. VKTX and NTLA
Already printing calls on CRSP 16 Jan 75$ and 80$ strike. And NTLA 16 Jan 25$ and 22.5$ 🚀
No plays because NTLA calls are going to continue to print for me until 1/16/26
Yes this! NTLA I am so in.
Intriguing… look at NUVB (trust in 3/26 $5C ) and NTLA - long long
She bought NTLA too … biotech on the menu for her ark this month
If you want to get into gene editing, then CRSP is the wrong way. It's old tech. No one does ex-vivo therapy since it's very expensive, far too invasive and not some thing you can mass produce to make profitable. $2M-$3M per patient, what insurance company is going to pay that. Requires flushing out all your bone marrow to work, far to invasive. Even CRSP knows this since they are now pivoting towards in-vivo which is non-invasive, can be mass produced, and can therefore can be commercialized. All CRSP wanted to do was get first to market but they are now so far behind with in-vivo. It's the reason why VERV got bought out and NTLA is pumping.
WSB doesnt let me post original posts. I wanted to post about NTLA at 9$ in May. CRSP is a great company, however NTLA is where the explosive growth is, in early 2026 it will be $40 solid. Insiders buying, positive trial news
CRBU and NTLA. What are your thoughts? Of course I'm a bag holder
If you liked my NTLA pick, you’re going to love ABEO.
Woah, NTLA... Cathy will be happy, but I'm still down.
Cathie Wood you hot bish. NTLA up almost 20%, SNPS up 10%, FIG 7%
Yep, time to buy NTLA and the Crispr plays, super out of favor, and on their way to FDA approvals.
CRSP is probably my riskiest one. I do like the space of gene editing but many others like BEAM and NTLA also doing well. They have good cash reserves and good progress. But 2 major factors for me… 1. While treating sickle cell is great, not much scale. But their phase 1 CTX310 is looking promising and focuses on cardiovascular health which is huge. I believe gene therapy is at infancy still and promising. 2. Recently a board director just bought a massive $50M mid-July. Some secondary factors… they have good cash runway, great brand recognition and this admin may be more favorable to medical trials and innovation. Could also be an acquisition target if trials progress. I don’t expect much day-to-day but don’t want to miss trial progress news or even acquisition.
I’m surprised NTLA isn’t discussed more
Should I yolo my 90 year old mothers savings into $CRSP $BEAM and $NTLA ?
Why are CRISPR stocks ($BEAM, $CRSP, $NTLA) so heavily shorted?
So I’ve used ChatGPT in a loosely similar manner, and the complexity of the prompt (plus deep level follow on conversation) is what really helps drill down to what you’re looking for. Based on a lengthy discussion about thesis, aggressiveness, convictions, etc, I asked it to recommend 10 stocks to round out exposure in key areas, and it recommended BLK, COIN, VRTX, REGN, NTLA, CRSP, SNOW, PDYN, SMR, and ARKW ETF. I made purchases of three of these and I’m up ~40% since.
NTLA will kiss $15 today or tomorrow
Have you considered adding NTLA to the mix? Good clinical results, sound management and first in vivo bla planned for next year.
NTLA’s really become my golden child. Up and to the right, day in and day out, whether there’s news or not. Don’t understand how 30% of the float is still short on a stock that’s up 52% this month. Those bastards must be fucking sweating
Thank you, OPEN, that was a quick way to lose money and the fastest my stop loss has ever triggered. May buy back in because I’m a masochist I guess? Whole market getting killed but NTLA still doing it for me. First shares I bought are now +65%, overall +23%. Nice that when it retrenches it never seems to fall too far
I like biotech stocks or ETFs. One of the last high growth areas that hasn’t recovered. Names like NTLA VKTX GPCR still have lots of room to grow and AI is going to make everything cheaper and more efficient for doing research.
Check out the float on NTLA
All of them follow the same trend - EDIT, CRBU, NTLA, PACB The "smaller" CRISPR stocks hit higher percentage gains but take bigger beatings, too. The ones I'd be interested in optioning would be EDIT and CRBU. But I'd rather buy the shares outright TBH
Some biotech plays I'm watching: NTLA - functional cure for genetic liver diseases, Regeneron-partnered, already starting to move up. Cashed up for another 2 years, and will benefit the most from the coming Fed cuts to reduce future funding costs even further. CELC - a P3 breast cancer readout is coming next month. Success means this will become the standard of care within 6-12 months. MSCLF - attempting to cure Duchenne by restoring muscle stem cell division in patients. Cashed up until end of 2026, with a major P2 readout in Jan'26. They completely healed 2 Duchenne dogs and is dosing the first kids in the USA soon. 3 month trial length for interim.
Add $NTLA to your portfolio and hold on to it, definitely through this year, but equally important through end of 2027 or 2028 or at least until they get acquired if it happens before then.
$NTLA......BIG time!!!! Biotech company specializing in gene editing therapies, therapies in their pipeline are in phase 3 with very positive results, additional therapies on hold as they focus on phase 3 pushing to commercializing, have solid partners such as Regeneron and Novartis on some of therapies in pipeline. By solid partners I mean they have invested in NTLA with Regeneron pouring millions at various stages, and Novartis with similar approach. An acquisition is definitely a potential which will be great and skyrocketing share price overnight, but NTLA has enough legs to go beyond that potential and into quite a few multiples if they go all the way on their own. Intellia Therapeutics (NTLA) is a market leader in in-vivo (Eli Lilly just acquired VERV recently, who is actually not as advanced as $NTLA in in-vivo), and NTLA also does ex-vivo. Current cash on hand enough to take them to commercializing gene editing therapies. Valuation is ridiculous low at close to cash on hand, thus market potential is not priced in as of yet, this is absolutely critical to get in RIGHT NOW!!!
$NTLA is about to skyrocket, and will continue in upward trajectory for months to come between now and 2026. The only thing that could stop its rise, is if Big Pharma acquires them before they go to commercialization phase, which is actually still great news because price with skyrocket overnight; but if no acquisition takes place then $NTLA will go up tremendously. Depending how much you have in it, potentially generational wealth building. This is the time to buy and hold, right NOW with prices in the \~$12.x/share. $NTLA will be in the $30-60 in next few months, and way more as we go into 2026
NTLA keeps moving up over the last couple weeks
Check a couple of my biotech gains today and ask yourself why are you feeding MM theta HUMA CLDI ICU NTLA PSTV XAIR IBIO PCSA TOVX That’s just a taste my port is full of ticking time bombs it only takes one to pull a DRUG it’s like playing the lottery with better odds that involves some kind of skill
Anyone else is into NTLA? I loaded